Elmore J L, Quattlebaum J T
Coastal Empire Community Mental Health Center, Beaufort, SC 29902, USA.
Pharmacotherapy. 1997 May-Jun;17(3):612-6.
Three women with several diagnoses, including depression and psychosis, personality disorder, attention deficit hyperactivity disorder, alcohol abuse, and physical disease, were treated with selective serotonin reuptake inhibitors (fluoxetine, paroxetine, fluvoxamine). One patient was prescribed paroxetine in addition to methylphenidate. While receiving these agents, two women experienced undesirable sexual arousal and the third had increased sexual desire, arousal, and hypersexuality.
三名患有多种疾病的女性，包括抑郁症、精神病、人格障碍、注意力缺陷多动障碍、酒精滥用和躯体疾病，接受了选择性5-羟色胺再摄取抑制剂（氟西汀、帕罗西汀、氟伏沙明）治疗。一名患者除哌甲酯外还服用了帕罗西汀。在服用这些药物期间，两名女性出现了不良性唤起，第三名女性出现了性欲增强、性唤起和性欲亢进。
